Atlas Trials

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

Clinical trial NCT05295680 · RECRUITING

Trial details

NCT number
NCT05295680
Sponsor
Aparna Goel
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Sclerosing Cholangitis
Start date
2023-05-10
Primary completion
2027-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.